Actual figures won’t be disclosed until 20 March, however the group said both divisions had seen solid operating profits, with Cello Health’s margin holding at 20%, and the Consumer division restoring its margin to double digits.

On the Consumer side in particular, Cello said growth had been helped by “a single large, non-recurring contract from an existing client [that] expanded rapidly in the second half” of the year.

Though this won’t be repeated in 2014, Cello said: “The diverse blue-chip client base of Cello Consumer provides several opportunities to replace it during 2014.”

Cello is working towards a rebranding of the Consumer division, which will become Cello Signal early into the second quarter of this year.

Pictured is CEO Mark Scott.